Market Research Reports

Home Press Releases Global Molecular Diagnostics Market Poised to reach US$8.7 bn by 2019 owing to Expanding Aging Population Base and Rise in Cancer Cases

Global Molecular Diagnostics Market Poised to reach US$8.7 bn by 2019 owing to Expanding Aging Population Base and Rise in Cancer Cases

Posted on Oct 13, 2015

The widening scope of applications of molecular diagnostics will create a US$8.7 bn market by the end of 2019, finds a latest study by Transparency Market Research (TMR). The market intelligence firm, in its report, titled ‘Molecular Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,’ states that the global molecular diagnostics market had a valuation of US$4.3 bn as of 2012. With several factors boosting both awareness of and demand for molecular diagnostics, the market will register a CAGR of 11.1% through the forecast period of the report.


Browse Full  Molecular Diagnostics Market (PCR, Next Generation Sequencing, Microarray, Infectious diseases, Genetic disease, Oncology testing, Blood donor screening) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 Research Report With Full TOC @


An uptick in the prevalence of cancer across the world will aid the adoption of molecular diagnostic methods, fuelling the growth of the market for molecular diagnostics. Besides this key factor, an expanding aging population base worldwide calls for the use of various diagnostic techniques in order to treat different diseases and medical conditions. Personalized medicine is emerging as a major trend in the pharmaceutical industry, and this factor will also contribute to the growth of the global molecular diagnostics market. However, the reimbursement scenario in many countries is currently not favorable to the growth of the molecular diagnostics market.


The report identifies two key opportunities: Technological innovation in molecular diagnostics to attain a higher share of the market and tapping unmet needs in the diagnostics market in emerging countries.For the purpose of this study, the global molecular diagnostics market is segmented on the basis of the following criteria: Diagnostic technology, applications, and geography.


By technology, the market is segmented into transcription mediated amplification (TMA), polymerase chain reaction (PCR), hybridization (FISH and ISH), microarray, and next-generation sequencing. The demand for next generation sequencing is growing rapidly thanks to the high sensitivity of these tests and their rapid turnaround time coupled with a decline in the prices of next generation sequencing technologies. Although the PCR market stood as the largest in 2012 in the global molecular diagnostics market by technology type, it will decline gradually over the report’s forecast period.

On the basis of applications, the molecular diagnostics market studies infectious disease, genomics, blood donor screening, and others. According to TMR’s report, about 50% of all revenue of the molecular diagnostics market comes from the infectious disease segment. This segment is also poised for healthy growth in the coming years thanks to an alarming increase in the incidence of hospital acquired infections (HAI). This will also boost the growth of the HAI testing market, making it the fastest growing segment in the market for molecular diagnostics for infectious disease. The report pegs the CAGR of the HAI testing market at 15.1% between 2013 and 2019.


From the geographical standpoint, the regions covered in the market are: North America, Europe, Asia Pacific, and Rest of the World. While North America and Europe are currently the largest regional markets for molecular diagnostic technologies, the Asia Pacific market will exhibit robust growth over the next few years. The incidence of cancer is rising rapidly in Asia Pacific, and this aspect will play a vital role in boosting the molecular diagnostics market in national markets within the Asia Pacific region. More money is being invested in proteomics and genomics in emerging economies in Asia Pacific, feeding the growth of the molecular diagnostics market.


The global molecular diagnostics market is segmented into the following categories:

  • Molecular Diagnostics Market, by Technology
    • PCR
    • Transcription mediated amplification (TMA)
    • Next generation sequencing
    • Microarray
    • Hybridization techniques
    • Others
  • Molecular Diagnostics Market, by Application
    • Infectious diseases
      • Virology
        • HIV testing
        • HPV testing
        • HCV testing
        • Others
      • Bacteriology
        • HAI testing
        • CT/NG testing
        • Others
      • Genomics
        • Genetic testing for inherited disorders
        • Human Leukocyte Antigen (HLA) testing
        • Pharmacogenetics testing
        • Oncology Testing
      • Blood Donor Screening
      • Others
    • Molecular Diagnostics Market, by Geography
      • North America
      • Europe
      • Asia-Pacific
      • RoW



About Us


Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.


TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.





Mr. Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453


Related Report

Copyright @ Transparency Market Research